We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT05356741
Brief Title: To Access the Safety and Effects of Intravenous Administration of AMX-818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

First Submitted : April 26, 2022
First Submitted that Met QC Criteria : April 26, 2022
First Posted : May 2, 2022

Last Update Submitted that Met QC Criteria : May 2, 2023
Last Update Posted : May 6, 2023